Knowledge and Awareness of Generative Artificial Intelligence Use in Medicine Among International Stakeholders: A Cross-Sectional Study

Xufei Luo , Bingyi Wang , Yule Li , Shuang Liu , Haodong Li , Yaxuan Ren , Wah Yang , Kyle Lam , Stephen R Ali , Gemma Sharp , Fabio Ynoe Moraes , Ye Wang , Di Zhu , Zhenhua Yang , Daher Mohammad , Robert Fruscio , Maged N. Kamel Boulos , Zhicheng Lin , Kazuki Ide , Xuping Song , Lu Zhang , Yih Chung Tham , Hui Liu , Long Ge , Yaolong Chen , Zhaoxiang Bian

Journal of Evidence-Based Medicine ›› 2025, Vol. 18 ›› Issue (2) : e70034

PDF
Journal of Evidence-Based Medicine ›› 2025, Vol. 18 ›› Issue (2) : e70034 DOI: 10.1111/jebm.70034
ARTICLE

Knowledge and Awareness of Generative Artificial Intelligence Use in Medicine Among International Stakeholders: A Cross-Sectional Study

Author information +
History +
PDF

Abstract

Objective: To assess the knowledge, attitudes, and practices (KAP) of medical stakeholders regarding the use of generative artificial intelligence (GAI) tools.

Methods: A cross-sectional survey was conducted among stakeholders in medicine. Participants included researchers, clinicians, and medical journal editors with varying degrees of familiarity with GAI tools. The survey questionnaire comprised 40 questions covering four main dimensions: basic information, knowledge, attitudes, and practices related to GAI tools. Descriptive analysis, Pearson's correlation, and multivariable regression were used to analyze the data.

Results: The overall awareness rate of GAI tools was 93.3%. Participants demonstrated moderate knowledge (mean score 17.71 ± 5.56), positive attitudes (mean score 73.32 ± 15.83), and reasonable practices (mean score 40.70 ± 12.86). Factors influencing knowledge included education level, geographic region, and attitudes (p < 0.05). Attitudes were influenced by work experience and knowledge (p < 0.05), while practices were driven by both knowledge and attitudes (p < 0.001). Participants from outside China scored higher in all dimensions compared to those from China (p < 0.001). Additionally, 74.0% of participants emphasized the importance of reporting GAI usage in research, and 73.9% advocated for naming the specific tool used.

Conclusion: The findings highlight a growing awareness and generally positive attitude toward GAI tools among medical stakeholders, alongside the recognition of their ethical implications and the necessity for standardized reporting practices. Targeted training and the development of clear reporting guidelines are recommended to enhance the effective use of GAI tools in medical research and practice.

Keywords

ChatGPT / cross-sectional survey / generative artificial intelligence / knowledge and awareness

Cite this article

Download citation ▾
Xufei Luo, Bingyi Wang, Yule Li, Shuang Liu, Haodong Li, Yaxuan Ren, Wah Yang, Kyle Lam, Stephen R Ali, Gemma Sharp, Fabio Ynoe Moraes, Ye Wang, Di Zhu, Zhenhua Yang, Daher Mohammad, Robert Fruscio, Maged N. Kamel Boulos, Zhicheng Lin, Kazuki Ide, Xuping Song, Lu Zhang, Yih Chung Tham, Hui Liu, Long Ge, Yaolong Chen, Zhaoxiang Bian. Knowledge and Awareness of Generative Artificial Intelligence Use in Medicine Among International Stakeholders: A Cross-Sectional Study. Journal of Evidence-Based Medicine, 2025, 18(2): e70034 DOI:10.1111/jebm.70034

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2025 Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.

AI Summary AI Mindmap
PDF

10

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/